HOUSE BILL NO. 1367 103RD GENERAL ASSEMBLY
INTRODUCED BY REPRESENTATIVE SELF.
2770H.01I JOSEPH ENGLER, Chief Clerk
AN ACT To repeal section 195.017, RSMo, and to enact in lieu thereof two new sections relating to abortifacient drugs, with a penalty provision.
Be it enacted by the General Assembly of the state of Missouri, as follows:
Section A. Section 195.017, RSMo, is repealed and two new sections enacted in lieu 2 thereof, to be known as sections 195.017 and 579.018, to read as follows: 195.017. 1. The department of health and senior services shall place a substance in 2 Schedule I if it finds that the substance: 3 (1) Has high potential for abuse; and 4 (2) Has no accepted medical use in treatment in the United States or lacks accepted 5 safety for use in treatment under medical supervision. 6 2. Schedule I: 7 (1) The controlled substances listed in this subsection are included in Schedule I; 8 (2) Any of the following opiates, including their isomers, esters, ethers, salts, and 9 salts of isomers, esters, and ethers, unless specifically excepted, whenever the existence of 10 these isomers, esters, ethers and salts is possible within the specific chemical designation: 11 (a) Acetyl-alpha-methylfentanyl (N-(1-(1-methyl-2-phenethyl)-4-piperidinyl)-N- 12 phenylacetamide); 13 (b) Acetylmethadol; 14 (c) Acetyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide); 15 (d) Acryl fentanyl (-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide); 16 (e) AH-7921(3,4-dichloro-N-[(1-dimethylamino) cyclohexylmethyl] benzamide); 17 (f) Allylprodine;
EXPLANATION — Matter enclosed in bold-faced brackets [thus] in the above bill is not enacted and is intended to be omitted from the law. Matter in bold-face type in the above bill is proposed language. HB 1367 2
18 (g) Alphacetylmethadol (except levoalphacetylmethadol, also known as levo-alpha- 19 acetylmethadol levothadyl acetate or LAAM); 20 (h) Alphameprodine; 21 (i) Alphamethadol; 22 (j) Alpha-methylfentanyl (N-1-(alphamethyl-beta-phenyl) ethyl-4-piperidyl) 23 propionanilide; 1-(1-methyl-2-phenylethyl)-4 ((N-propanilido) piperidine); 24 (k) Alpha-methylthiofentanyl (N-(1-methyl-2-(2-thienyl) ethyl-4-piperidinyl)-N- 25 phenylpropanamide); 26 (l) Benzethidine; 27 (m) Betacetylmethadol; 28 (n) Beta-hydroxyfentanyl (N-(1-(2-hydroxy-2-phenethyl)-4-piperidinyl)-N- 29 phenylpropanamide); 30 (o) Beta-hydroxy-3-methylfentanyl (N-(1-(2-hydroxy-2-phenethyl)-3-methyl-4- 31 piperidinyl)-N-phenylpropanamide); 32 (p) Betameprodine; 33 (q) Betamethadol; 34 (r) Betaprodine; 35 (s) Clonitazene; 36 (t) Dextromoramide; 37 (u) Diampromide; 38 (v) Cyclopropyl fentanyl; 39 (w) Diethylthiambutene; 40 (x) Difenoxin; 41 (y) Dimenoxadol; 42 (z) Dimepheptanol; 43 (aa) Dimethylthiambutene; 44 (bb) Dioxaphetyl butyrate; 45 (cc) Dipipanone; 46 (dd) Ethylmethylthiambutene; 47 (ee) Etonitazene; 48 (ff) Etoxeridine; 49 (gg) 4-fluoroisobutyryl fentanyl -(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl) 50 isobutyramide; 51 (hh) Furanyl fentanyl -(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide; 52 (ii) Furethidine; 53 (jj) Hydroxypethidine; 54 (kk) Ketobemidone; HB 1367 3
55 (ll) Levomoramide; 56 (mm) Levophenacylmorphan; 57 (nn) 3-Methylfentanyl (N-(3-methyl-1-(2-phenylethyl)-4-piperidyl)-N- 58 phenylproanamide), its optical and geometric isomers, salts, and salts of isomers; 59 (oo) 3-Methylthiofentanyl (N-((3-methyl-1-(2-thienyl)ethyl-4-piperidinyl)-N- 60 phenylpropanamide); 61 (pp) Methoxyacetyl fentanyl (2-methoxy-N-(1-phenethylpiperidin-4-yl)-N- 62 phenylacetamide); 63 (qq) Morpheridine; 64 (rr) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine); 65 (ss) MT-45(1-cyclohexyl-4-(1,2-diphenylethyl) piperazine); 66 (tt) Noracymethadol; 67 (uu) Norlevorphanol; 68 (vv) Normethadone; 69 (ww) Norpipanone; 70 (xx) Ocfentanil N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl) 71 acetamide; 72 (yy) Ortho-fluorofentanyl (N-2-(1-phenethylpiperidin-yl)propionamide); other name 73 2-fluorofentanyl; 74 (zz) para-fluorobutyryl fentanyl (N-4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl) 75 butyramide; 76 (aaa) Para-fluorofentanyl (N-(4-fluorophenyl)-N-(1-(2-phenethyl)-4-piperidinyl) 77 propanamide; 78 (bbb) PEPAP (1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine); 79 (ccc) Phenadoxone; 80 (ddd) Phenampromide; 81 (eee) Phenomorphan; 82 (fff) Phenoperidine; 83 (ggg) Piritramide; 84 (hhh) Proheptazine; 85 (iii) Properidine; 86 (jjj) Propiram; 87 (kkk) Racemoramide; 88 (lll) Tetrahydrofuranyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N- 89 phenyltetrahydrofuran-2-carboxamide); 90 (mmm) Thiofentanyl (-phenyl-N-(1-(2-thienyl)ethyl-4-piperidinyl)-propanamide; 91 (nnn) Tilidine; HB 1367 4
92 (ooo) Trimeperidine; 93 (3) Any of the following opium derivatives, their salts, isomers and salts of isomers 94 unless specifically excepted, whenever the existence of these salts, isomers and salts of 95 isomers is possible within the specific chemical designation: 96 (a) Acetorphine; 97 (b) Acetyldihydrocodeine; 98 (c) Benzylmorphine; 99 (d) Codeine methylbromide; 100 (e) Codeine-N-Oxide; 101 (f) Cyprenorphine; 102 (g) Desomorphine; 103 (h) Dihydromorphine; 104 (i) Drotebanol; 105 (j) Etorphine (except hydrochloride salt); 106 (k) Heroin; 107 (l) Hydromorphinol; 108 (m) Methyldesorphine; 109 (n) Methyldihydromorphine; 110 (o) Morphine methylbromide; 111 (p) Morphine methylsulfonate; 112 (q) Morphine-N-Oxide; 113 (r) Myrophine; 114 (s) Nicocodeine; 115 (t) Nicomorphine; 116 (u) Normorphine; 117 (v) Pholcodine; 118 (w) Thebacon; 119 (4) Any of the following opiate similar synthetic substances scheduled by the U.S. 120 Drug Enforcement Administration as substances that share a pharmacological profile similar 121 to fentanyl, morphine, and other synthetic opioids, unless specifically excepted or unless 122 listed in another schedule: 123 (a) Butyryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide); 124 (b) U-47700 (3,4-Dichloro-N-[2-(dimethylamino) cyclohexyl]–methyl benzamide). 125 (5) Any material, compound, mixture or preparation which contains any quantity of 126 the following hallucinogenic substances, their salts, isomers and salts of isomers, unless 127 specifically excepted, whenever the existence of these salts, isomers, and salts of isomers is 128 possible within the specific chemical designation: HB 1367 5
129 (a) Alpha-ethyltryptamine; 130 (b) 4-bromo-2,5-dimethoxyamphetamine; 131 (c) 4-bromo-2,5-dimethoxyphenethylamine; 132 (d) 2,5-dimethoxyamphetamine; 133 (e) 2,5-dimethoxy-4-ethylamphetamine; 134 (f) 2,5-dimethoxy-4-(n)-propylthiophenethylamine; 135 (g) 2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine; 136 (h) 2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine; 137 (i) 2-(2,5-Dimethoxy-4-methylphenyl) ethanamine; 138 (j) 2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine; 139 (k) 2-(2,5-Dimethoxyphenyl) ethanamine; 140 (l) 2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine; 141 (m) 2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine; 142 (n) 2-(4-Iodo-2,5-dimethoxyphenyl) ethanamine; 143 (o) 2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine; 144 (p) 4-methoxyamphetamine; 145 (q) 5-methoxy-3,4-methylenedioxyamphetamine; 146 (r) 4-methyl-2, 5-dimethoxyamphetamine; 147 (s) 3,4-methylenedioxyamphetamine; 148 (t) 3,4-methylenedioxymethamphetamine; 149 (u) 3,4-methylenedioxy-N-ethylamphetamine; 150 (v) N-hydroxy-3, 4-methylenedioxyamphetamine; 151 (w) 3,4,5-trimethoxyamphetamine; 152 (x) 5-MeO-DMT or 5-methoxy-N,N-dimethyltryptamine; 153 (y) Alpha-methyltryptamine; 154 (z) Bufotenine; 155 (aa) Diethyltryptamine; 156 (bb) Dimethyltryptamine; 157 (cc) 5-methoxy-N,N-diisopropyltryptamine; 158 (dd) Ibogaine; 159 (ee) Lysergic acid diethylamide; 160 (ff) Marijuana or marihuana, except industrial hemp; 161 (gg) Mescaline; 162 (hh) Parahexyl; 163 (ii) Peyote, to include all parts of the plant presently classified botanically as 164 Lophophora williamsii Lemaire, whether growing or not; the seeds thereof; any extract from HB 1367 6
165 any part of such plant; and every compound, manufacture, salt, derivative, mixture or 166 preparation of the plant, its seed or extracts; 167 (jj) N-ethyl-3-piperidyl benzilate; 168 (kk) N-methyl-3-piperidyl benzilate; 169 (ll) Psilocybin; 170 (mm) Psilocyn; 171 (nn) Tetrahydrocannabinols naturally contained in a plant of the genus Cannabis 172 (cannabis plant), except industrial hemp, as well as synthetic equivalents of the substances 173 contained in the cannabis plant, or in the resinous extractives of such plant, or synthetic 174 substances, derivatives and their isomers, or both, with similar chemical structure and 175 pharmacological activity to those substances contained in the plant, such as the following: 176 a. 1 cis or trans tetrahydrocannabinol and their optical isomers; 177 b. 6 cis or trans tetrahydrocannabinol and their optical isomers; 178 c. 3,4 cis or trans tetrahydrocannabinol and their optical isomers; 179 d. Any compounds of these structures, regardless of numerical designation of atomic 180 positions covered; 181 (oo) Ethylamine analog of phencyclidine; 182 (pp) Pyrrolidine analog of phencyclidine; 183 (qq) Thiophene analog of phencyclidine; 184 (rr) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine; 185 (ss) Salvia divinorum; 186 (tt) Salvinorin A; 187 (uu) Synthetic cannabinoids: 188 a. Any compound structurally derived from 3-(1-naphthoyl)indole or 1H-indol-3-yl- 189 (1-naphthyl)methane by substitution at the nitrogen atom of the indole ring by alkyl, 190 haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or 2- 191 (4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent, 192 whether or not substituted in the naphthyl ring to any extent. Including, but not limited to: 193 (i) AM2201, or 1-(5-fluoropentyl)-3-(1-naphthoyl)indole; 194 (ii) JWH-007, or 1-pentyl-2-methyl-3-(1-naphthoyl)indole; 195 (iii) JWH-015, or 1-propyl-2-methyl-3-(1-naphthoyl)indole; 196 (iv) JWH-018, or 1-pentyl-3-(1-naphthoyl)indole; 197 (v) JWH-019, or 1-hexyl-3-(1-naphthoyl)indole; 198 (vi) JWH-073, or 1-butyl-3-(1-naphthoyl)indole; 199 (vii) JWH-081, or 1-pentyl-3-(4-methoxy-1-naphthoyl)indole; 200 (viii) JWH-098, or 1-pentyl-2-methyl-3-(4-methoxy-1-naphthoyl)indole; 201 (ix) JWH-122, or 1-pentyl-3-(4-methyl-1-naphthoyl)indole; HB 1367 7
202 (x) JWH-164, or 1-pentyl-3-(7-methoxy-1-naphthoyl)indole; 203 (xi) JWH-200, or 1-(2-(4-(morpholinyl)ethyl))-3-(1-naphthoyl)indole; 204 (xii) JWH-210, or 1-pentyl-3-(4-ethyl-1-naphthoyl)indole; 205 (xiii) JWH-398, or 1-pentyl-3-(4-chloro-1-naphthoyl)indole; 206 b. Any compound structurally derived from 3-(1-naphthoyl)pyrrole by substitution at 207 the nitrogen atom of the pyrrole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, 208 cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether 209 or not further substituted in the pyrrole ring to any extent, whether or not substituted in the 210 naphthyl ring to any extent; 211 c. Any compound structurally derived from 1-(1-naphthylmethyl)indene by 212 substitution at the 3-position of the indene ring by alkyl, haloalkyl, alkenyl, 213 cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl) 214 ethyl group, whether or not further substituted in the indene ring to any extent, whether or not 215 substituted in the naphthyl ring to any extent; 216 d. Any compound structurally derived from 3-phenylacetylindole by substitution at 217 the nitrogen atom of the indole ring with alkyl, haloalkyl, alkenyl, cycloalkylmethyl, 218 cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether 219 or not further substituted in the indole ring to any extent, whether or not substituted in the 220 phenyl ring to any extent. Including, but not limited to: 221 (i) JWH-201, or 1-pentyl-3-(4-methoxyphenylacetyl)indole; 222 (ii) JWH-203, or 1-pentyl-3-(2-chlorophenylacetyl)indole; 223 (iii) JWH-250, or 1-pentyl-3-(2-methoxyphenylacetyl)indole; 224 (iv) JWH-251, or 1-pentyl-3-(2-methylphenylacetyl)indole; 225 (v) RCS-8, or 1-(2-cyclohexylethyl)-3-(2-methoxyphenylacetyl)indole; 226 e. Any compound structurally derived from 2-(3-hydroxycyclohexyl)phenol by 227 substitution at the 5-position of the phenolic ring by alkyl, haloalkyl, alkenyl, 228 cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl) 229 ethyl group, whether or not substituted in the cyclohexyl ring to any extent. Including, but 230 not limited to CP 47, 497 and homologues, or 2-[(1R,3S)-3-hydroxycyclohexyl]-5-(2- 231 methyloctan-2-yl)phenol, where side chain n=5, and homologues where side chain n-4,6, or 232 7; 233 f. Any compound containing a 3-(benzoyl)indole structure with substitution at the 234 nitrogen atom of the indole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, 235 cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, 236 whether or not further substituted in the indole ring to any extent and whether or not 237 substituted in the phenyl ring to any extent. Including, but not limited to: 238 (i) AM-694, or 1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole; HB 1367 8
239 (ii) RCS-4, or 1-pentyl-3-(4-methoxybenzoyl)indole (SR-19 and RCS-4); 240 g. CP 50,556-1, or [(6S,6aR,9R,10aR)-9-hydroxy-6-methyl-3-[(2R)-5-phenylpentan- 241 2-yl] oxy-5,6,6a,7,8,9,10,10a-octahydrophenanthridin-1-yl] acetate; 242 h. HU-210, or (6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)- 243 6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol; 244 i. HU-211, or Dexanabinol,(6aS,10aS)-9-(hydroxymethyl)-6,6-dimethyl-3-(2- 245 methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol; 246 j. Dimethylheptylpyran, or DMHP; 247 (6) Any material, compound, mixture or preparation containing any quantity of the 248 following substances having a depressant effect on the central nervous system, including their 249 salts, isomers and salts of isomers whenever the existence of these salts, isomers and salts of 250 isomers is possible within the specific chemical designation: 251 (a) Gamma-hydroxybutyric acid; 252 (b) Mecloqualone; 253 (c) Methaqualone; 254 (7) Any material, compound, mixture or preparation containing any quantity of the 255 following substances having a stimulant effect on the central nervous system, including their 256 salts, isomers and salts of isomers: 257 (a) Aminorex; 258 (b) N-benzylpiperazine; 259 (c) Cathinone; 260 (d) Fenethylline; 261 (e) 3-Fluoromethcathinone; 262 (f) 4-Fluoromethcathinone; 263 (g) Mephedrone, or 4-methylmethcathinone; 264 (h) Methcathinone; 265 (i) 4-methoxymethcathinone; 266 (j) (+,-)cis-4-methylaminorex ((+,-)cis-4,5-dihydro-4-methyl-5-phenyl-2- 267 oxazolamine); 268 (k) Methylenedioxypyrovalerone, MDPV, or 1-(1,3-Benzodioxol-5-yl)-2-(1- 269 pyrrolidinyl)-1-pentanone; 270 (l) Methylone, or 3,4-Methylenedioxymethcathinone; 271 (m) 4-Methyl-alpha-pyrrolidinobutiophenone, or MPBP; 272 (n) N-ethylamphetamine; 273 (o) N,N-dimethylamphetamine; 274 (p) Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate (PB-22; QUPIC); HB 1367 9
275 (q) Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (5-fluoro-PB-22; 5F- 276 PB-22); 277 (r) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3- 278 carboxamide (AB-FUBINACA); 279 (s) N-(1-amino-3, 3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide 280 (ADB-PINACA); 281 (8) A temporary listing of substances subject to emergency scheduling under federal 282 law shall include any material, compound, mixture or preparation which contains any 283 quantity of the following substances: 284 (a) (1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone, its optical, 285 positional, and geometric isomers, salts, and salts of isomers; 286 (b) [1-(5-fluoro-pentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone, 287 its optical, positional, and geometric isomers, salts, and salts of isomers; 288 (c) N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide, its optical, positional, and 289 geometric isomers, salts, and salts of isomers; 290 (d) 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine, its optical, 291 positional, and geometric isomers, salts, and salts of isomers; 292 (e) 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine, its optical, 293 positional, and geometric isomers, salts, and salts of isomers; 294 (f) 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine, its optical, 295 positional, and geometric isomers, salts, and salts of isomers; 296 (g) 4-methyl-N-ethylcathinone, its optical, positional, and geometric isomers, salts, 297 and salts of isomers; 298 (h) 4-methyl-alpha-pyrrolidinopropiophenone, its optical, positional, and geometric 299 isomers, salts, and salts of isomers; 300 (i) Alpha-pyrrolidinopentiophenone, its optical, positional, and geometric isomers, 301 salts, and salts of isomers; 302 (j) Butylone, its optical, positional, and geometric isomers, salts, and salts of isomers; 303 (k) Pentedrone, its optical, positional, and geometric isomers, salts, and s